Davos 2026: Meta Chief Global Affairs Officer Joel Kaplan 1/23/26
Squawk Pod23 Jan

Davos 2026: Meta Chief Global Affairs Officer Joel Kaplan 1/23/26

Joel Kaplan, Meta’s chief global affairs officer, discusses the company’s $600 billion push into AI infrastructure and U.S. jobs from the World Economic Forum in Davos. He outlines Meta’s superintelligence ambitions and the future of its Llama AI model and maps out global AI regulation.

In this episode:

Joel Kaplan, @joel_kaplan

Becky Quick, @BeckyQuick

Joe Kernen, @JoeSquawk

Andrew Ross Sorkin, @andrewrsorkin

Cameron Costa, @CameronCostaNY


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2034)

USTR Jamieson Greer & a GPU Lifecycle 8/24/26

USTR Jamieson Greer & a GPU Lifecycle 8/24/26

After the U.S. treasury yields surged to levels not seen in nearly 20 years, U.S. Treasury Secretary Scott Bessent announced that the Treasury would double the size of its government debt repurchases....

24 Aug 42min

Debating a California Wealth Tax & Adding AI to Therapy 8/21/26

Debating a California Wealth Tax & Adding AI to Therapy 8/21/26

Proposition 40, a proposed wealth tax in California, has sparked heated debate among investors, tech founders, and billionaires. Venture capitalist Ben Narasin argues that the tax and the solutions pu...

21 Aug 35min

U.S. Debt, Data Centers in the Midterms, & Coinbase CEO 8/20/26

U.S. Debt, Data Centers in the Midterms, & Coinbase CEO 8/20/26

The morning after crypto and tech leaders met President Trump at the White House, attendee and Coinbase CEO Brian Armstrong discusses the Clarity Act vote in September. Armstrong is optimistic that cr...

20 Aug 37min

Moderna & Merck’s Cancer Treatment Win & Figma CEO 8/19/26

Moderna & Merck’s Cancer Treatment Win & Figma CEO 8/19/26

Shares of Moderna and Merck are surging on positive results from a Phase 3 trial of a groundbreaking cancer treatment. After a decade in development, individualized mRNA “vaccines” and established can...

19 Aug 42min

AI “Genies” & Hims & Hers CEO Andrew Dudum 8/18/26

AI “Genies” & Hims & Hers CEO Andrew Dudum 8/18/26

In an exclusive, rare interview, CEO and co-founder of Hims & Hers Andrew Dudum sits down with Andrew Ross Sorkin. Dudum maps out his vision for an AI-enabled American healthcare system, comments on t...

18 Aug 54min

OpenAI President Greg Brockman: Now Is the Time to Act 8/17/26

OpenAI President Greg Brockman: Now Is the Time to Act 8/17/26

OpenAI co-founder and president Greg Brockman issues a call to amp up cybersecurity in the age of AI. Brockman addresses recent leadership departures at OpenAI, the open-weight model debate, and AI sa...

17 Aug 40min

A Wisconsin Upset & Gary Vee’s Next Bet 8/14/26

A Wisconsin Upset & Gary Vee’s Next Bet 8/14/26

Wisconsin’s Democratic primary for governor delivers a surprising result as pollster and strategist Frank Luntz discusses what it says about the state of the race and the growing influence of predicti...

14 Aug 29min

Truth Social’s Advantage & AI Anxiety 8/13/26

Truth Social’s Advantage & AI Anxiety 8/13/26

A lawsuit claims Truth Social is giving paid subscribers an unfair advantage by allowing them to see President Trump’s posts fractions of a second before other users. Former Assistant Attorney General...

13 Aug 26min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
lydartikler-fra-aftenposten
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
rss-skravla-gar
finansredaksjonen
utbytte
rss-pa-konto
pengepodden-2
lederpodden
livet-pa-veien-med-jan-erik-larssen
rss-orjasater
tid-er-penger-en-podcast-med-peter-warren
stormkast-med-valebrokk-stordalen
morgenkaffen-med-finansavisen
okonomiamatorene
liberal-halvtime
rss-markedspuls-2